Veeva Clinical Database Crosses 200 Study Milestone
Veeva Clinical Database (CDB) enables methods of managing clinical trial data, which can save customers 30 to 50% of the time required to aggregate, clean, and transform data. Since Veeva Systems announced its launch, Veeva CDB has cleaned more than 200,000 subjects to provide quality data across more than 200 studies.
"By launching Veeva CDB and building processes around it, we're laying a foundation for clinical data transformation," said Jerry Yarem, vice president, data management, Fortrea in a press release. "This is a significant advancement that can bring together all of our data sources and deliver clean data faster than ever so study teams can make data-driven decisions with confidence."
Veeva CDB automates processes for a method of cleaning data that increases productivity and efficiency. Using Veeva CDB Auto Checks, customers can identify discrepancies upon data ingestion and create queries or close them when issues are corrected. The application also automates change detection so data managers can focus efforts on new or updated data, saving time and lowering costs.
"Veeva CDB makes collaboration with study partners and data providers easy, simplifying data transfer and configuration," said Tonya Arthur, head of data management, Acelyrin in a press release. "Pairing Veeva's clinical data management platform and our CRO partner's expertise will improve our trial processes and provide the visibility to make informed decisions that can positively impact trial outcomes."
Sponsors and contract research organizations (CROs) use Veeva CDB to ingest and clean clinical data from a variety of system sources, including EDC systems such as Veeva Vault EDC and Medidata Rave™, ePRO, and lab data. In addition, the Veeva CDB Data Provider Program enables qualified partners with resources to gain operational efficiencies when delivering data for Veeva CDB customers.
"Data transfers to and from Veeva enable an integrated service offering that streamlines data delivery for our joint customers using Veeva CDB and Clinical Ink's comprehensive suite of eCOA, direct data capture, patient engagement, and digital biomarker technologies," said Son Ly, vice president, data services, Clinical Ink in a press release.
"As clinical data sources continue to grow and trial complexity increases, data managers need agile technologies to streamline the path toward clean data and insights," said Pavel Burmenko, general manager, Veeva CDB in a press release. "With more than 30 data providers supplying study data, Veeva CDB is gaining momentum, advancing clinical data management for seamless information exchange and faster access to high-quality data."
Reference
Veeva Clinical Database Crosses 200 Study Milestone, Cuts Time to Aggregate and Clean Study Data by 30-50%. (2023, August 21). Cision PR Newswire.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
